Objectives Celecoxib is a selective cyclooxygenase (COX)-2 inhibitor that is commonly used
to reduce the incidence of gastrointestinal (GI) complications in patients with rheumatoid …

ContextIn vitro studies have shown that celecoxib inhibits cyclooxygenase 2 (COX-2) but not
COX-1, suggesting that this drug may have anti-inflammatory and analgesic activity without …

The objective was to improve understanding of adverse events occurring with celecoxib in
the treatment of osteoarthritis and rheumatoid arthritis. Data were extracted from company …

Introduction Although the safety of celecoxib has been investigated, limited data are
available on complications affecting the entire (upper and lower) gastrointestinal (GI) tract …

1.< div>< p> Ревматология. Клинические рекомендации. Под ред. акад. ЕЛ Насонова.
М.: ГЭОТАР-Медиа, 2010; 752 с.</p>< p> Амирджанова ВН, Кайгородцева ЕЮ, Горячев …

Objective: To determine the efficacy, gastrointestinal safety, and tolerability of celecoxib (a
cyclo-oxygenase 2 (COX 2) inhibitor) used in the treatment of osteoarthritis and rheumatoid …

Objective To determine the upper gastrointestinal (GI) tolerability of celecoxib, naproxen,
and placebo in patients with rheumatoid arthritis (RA) and osteoarthritis (OA). Methods An …

Objective. To compare the efficacy of etoricoxib 30 mg with the generally maximum
recommended dose of celecoxib, 200 mg, in the treatment of osteoarthritis (OA) in two …

Celecoxib is a selective cyclo-oxygenase 2 inhibitor licensed for use in musculoskeletal
symptoms as well as in primary dysmenorrhea and acute pain. One advantage celecoxib …

Background Rheumatoid arthritis (RA) is a systemic auto‐immune disorder, involving
persistent joint inflammation. NSAIDs are used to control the symptoms of RA, but are …